US4123610A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Nucleic acid crosslinking agent and affinity inactivation of nucleic acids therewith
Assignee: Government of the United States of America
•
Filing: 1977-03-09
•
Granted: 1978-10-31
•
Expires: 1997-03-09
Abstract
Abstract The crosslinking agent contains an acylhydrazide moiety, through which it is linked to a cytosine residue on the first chain; and an α-haloketal moiety which, after attachment of the crosslinking agent to the first chain, is hydrolyzed to an α-haloketone moiety, through which linking is effected to the base-paired guanine residue on the second chain.
Inventors
- 👤 James E. Summerton
- 👤 Paul A. Bartlett
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 01:40
CPC Classifications
C; C07; C07C; C07C243/00; C07H; C07H21/00
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
54 words
A crosslinking agent for covalently crosslinking the base-paired complementary polynucleotide chains of a double-stranded nucleic acid having cytosine and guanine residues, said crosslinking agent having the formula ##STR11## wherein n is an integer of from 2 to 4; R' is hydrogen or methyl; X is Cl or Br; and R is methyl or ethyl.
Claim 2
Dependent Claim
54 words
A crosslinking agent for covalently crosslinking the base-paired complementary polynucleotide chains of a double-stranded nucleic acid having cytosine and guanine residues, said crosslinking agent having the formula ##STR11## wherein n is an integer of from 2 to 4; R' is hydrogen or methyl; X is Cl or Br; and R is methyl or ethyl.
Claim 3
Dependent Claim
9 words
The crosslinking agent of claim 1, which is 6-bromo-5,5-dimethoxyhexanohydrazide.
Claim 4
Dependent Claim
9 words
The crosslinking agent of claim 1, which is 6-chloro-5,5-dimethoxyhexanohydrazide.
Claim 5
Dependent Claim
9 words
The crosslinking agent of claim 1, which is 6-chloro-5,5-diethoxyhexanohydrazide.
Claim 6
Dependent Claim
120 words
An affinity inactivating agent for nucleic acids which is adapted for use in selectively inactivating a guanine residue-containing single-stranded polynucleotide target chain having a designated nucleotide sequence by base-pairing and covalently crosslinking therewith, said affinity inactivating agent comprising a derivatized cytosine residue-containing single-stranded polynucleotide carrier chain which has a nucleotide sequence complementary to said designated nucleotide sequence and which is capable of base-pairing with said target chain, at least one of the cytosine residues of said derivatized carrier chain being a C-4-substituted cytosine residue having the formula ##STR12## wherein n is an integer of from 2 to 4; R' is hydrogen or methyl; X is Cl or Br; Y is ##STR13## when Y is ##STR14## R is methyl or ethyl.
Claim 7
Dependent Claim
120 words
An affinity inactivating agent for nucleic acids which is adapted for use in selectively inactivating a guanine residue-containing single-stranded polynucleotide target chain having a designated nucleotide sequence by base-pairing and covalently crosslinking therewith, said affinity inactivating agent comprising a derivatized cytosine residue-containing single-stranded polynucleotide carrier chain which has a nucleotide sequence complementary to said designated nucleotide sequence and which is capable of base-pairing with said target chain, at least one of the cytosine residues of said derivatized carrier chain being a C-4-substituted cytosine residue having the formula ##STR12## wherein n is an integer of from 2 to 4; R' is hydrogen or methyl; X is Cl or Br; Y is ##STR13## when Y is ##STR14## R is methyl or ethyl.
Claim 8
Dependent Claim
20 words
The affinity inactivating agent of claim 5, wherein said derivatized carrier chain contains a plurality of said C-4-substituted cytosine residues.
Claim 9
Dependent Claim
21 words
The affinity inactivating agent of claim 5, wherein ##STR15## X is Br, n is 3,R' is hydrogen and R is methyl.
Claim 10
Independent Claim
243 words
A method for the selective inactivation of a guanine residue-containing single-stranded polynucleotide target chain having a designated nucleotide sequence, comprising the steps of: (a) providing a cytosine residue-containing single-stranded polynucleotide carrier chain which has a nucleotide sequence complementary to said designated nucleotide sequence and which is capable of base-pairing with said target chain; (b) reacting said carrier chain with a crosslinking agent having the formula ##STR16## wherein n is an integer of from 2 to 4; R' is hydrogen or methyl; X is Cl or Br; and R is methyl or ethyl; so as to form a derivatized carrier chain wherein at least one of the cytosine residues of said carrier chain is covalently linked to the acylhydrazide moiety of a molecule of said crosslinking agent and thereby converted to a C-4-substituted cytosine residue having the formula ##STR17## wherein n, R', X and R have the meanings defined above; (c) activating said derivatized carrier chain by hydrolyzing the ##STR18## moiety of said C-4-substituted cytosine residues to a guanine residue-reactive ##STR19## moiety wherein R' and X have the meanings defined above; and (d) contacting said activated derivatized carrier chain with said target chain under substantially physiological conditions, whereby said carrier chain and said target chain become base-paired and said C-4-substituted cytosine residues of said carrier chain react through said guanine residue-reactive moiety with their respective base-paired guanine residues of said target chain to covalently crosslink the two chains and thereby inactivate said target chain.
Claim 11
Independent Claim
243 words
A method for the selective inactivation of a guanine residue-containing single-stranded polynucleotide target chain having a designated nucleotide sequence, comprising the steps of: (a) providing a cytosine residue-containing single-stranded polynucleotide carrier chain which has a nucleotide sequence complementary to said designated nucleotide sequence and which is capable of base-pairing with said target chain; (b) reacting said carrier chain with a crosslinking agent having the formula ##STR16## wherein n is an integer of from 2 to 4; R' is hydrogen or methyl; X is Cl or Br; and R is methyl or ethyl; so as to form a derivatized carrier chain wherein at least one of the cytosine residues of said carrier chain is covalently linked to the acylhydrazide moiety of a molecule of said crosslinking agent and thereby converted to a C-4-substituted cytosine residue having the formula ##STR17## wherein n, R', X and R have the meanings defined above; (c) activating said derivatized carrier chain by hydrolyzing the ##STR18## moiety of said C-4-substituted cytosine residues to a guanine residue-reactive ##STR19## moiety wherein R' and X have the meanings defined above; and (d) contacting said activated derivatized carrier chain with said target chain under substantially physiological conditions, whereby said carrier chain and said target chain become base-paired and said C-4-substituted cytosine residues of said carrier chain react through said guanine residue-reactive moiety with their respective base-paired guanine residues of said target chain to covalently crosslink the two chains and thereby inactivate said target chain.
Claim 12
Dependent Claim
65 words
The method of claim 8, wherein the reaction of said carrier chain with said cross-linking agent is carried out in a reaction medium comprising water and an alcohol selected from the group consisting of methanol and ethanol in a water to alcohol volume ratio of from 2:3 to 3:2, and the pH of said reaction medium is within the range of from 3.3 to 4.8.
Claim 13
Dependent Claim
33 words
The method of claim 8, wherein the activation of said derivatized carrier chain is carried out in an acidic aqueous activation medium having a pH within the range of from 2.5 to 3.5.
Claim 14
Dependent Claim
18 words
The method of claim 8, wherein said derivatized carrier chain contains a plurality of said C-4-substituted cytosine residues.
Claim 15
Dependent Claim
11 words
The method of claim 8, wherein said crosslinking agent is 6-bromo-5,5-dimethoxyhexanohydrazide.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-10-30 | 1982-05-01 | 1982-10-31 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-10-30 | 1986-05-01 | 1986-10-31 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-10-30 | 1990-05-01 | 1990-10-31 | $7700.00 | Window Closed / Lapsed |